middle.news
How Is Osteopore Turning Regulatory Wins Into Revenue Growth Amid Rising Losses?
4:37am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
How Is Osteopore Turning Regulatory Wins Into Revenue Growth Amid Rising Losses?
4:37am on Saturday 30th of August, 2025 AEST
Key Points
6% revenue growth to $1.56 million in H1 2025
Net loss after tax increased slightly to $1.63 million
Expanded regulatory approvals including EU MDR for custom implants
New distribution agreements in Thailand and the US
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Osteopore (ASX:OSX)
OPEN ARTICLE